GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CollPlant Biotechnologies Ltd (XTAE:CLGN) » Definitions » PS Ratio

CollPlant Biotechnologies (XTAE:CLGN) PS Ratio : 2.04 (As of May. 27, 2024)


View and export this data going back to 2007. Start your Free Trial

What is CollPlant Biotechnologies PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, CollPlant Biotechnologies's share price is ₪0.43. CollPlant Biotechnologies's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₪0.21. Hence, CollPlant Biotechnologies's PS Ratio for today is 2.04.

The historical rank and industry rank for CollPlant Biotechnologies's PS Ratio or its related term are showing as below:

XTAE:CLGN' s PS Ratio Range Over the Past 10 Years
Min: 5.25   Med: 10.99   Max: 481.11
Current: 6.18

During the past 12 years, CollPlant Biotechnologies's highest PS Ratio was 481.11. The lowest was 5.25. And the median was 10.99.

XTAE:CLGN's PS Ratio is ranked better than
62.1% of 1000 companies
in the Biotechnology industry
Industry Median: 9.055 vs XTAE:CLGN: 6.18

CollPlant Biotechnologies's Revenue per Sharefor the three months ended in Dec. 2023 was ₪0.01. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₪0.21.

Warning Sign:

CollPlant Biotechnologies Ltd revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue per Share Growth Rate of CollPlant Biotechnologies was 3463.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 2.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was -22.70% per year.

During the past 12 years, CollPlant Biotechnologies's highest 3-Year average Revenue per Share Growth Rate was 674.70% per year. The lowest was -61.30% per year. And the median was 4.60% per year.

Back to Basics: PS Ratio


CollPlant Biotechnologies PS Ratio Historical Data

The historical data trend for CollPlant Biotechnologies's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CollPlant Biotechnologies PS Ratio Chart

CollPlant Biotechnologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 12.52 309.26 6.64

CollPlant Biotechnologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 309.26 118.98 8.89 6.11 6.64

Competitive Comparison of CollPlant Biotechnologies's PS Ratio

For the Biotechnology subindustry, CollPlant Biotechnologies's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CollPlant Biotechnologies's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CollPlant Biotechnologies's PS Ratio distribution charts can be found below:

* The bar in red indicates where CollPlant Biotechnologies's PS Ratio falls into.



CollPlant Biotechnologies PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

CollPlant Biotechnologies's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.43/0.211
=2.04

CollPlant Biotechnologies's Share Price of today is ₪0.43.
CollPlant Biotechnologies's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪0.21.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


CollPlant Biotechnologies  (XTAE:CLGN) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


CollPlant Biotechnologies PS Ratio Related Terms

Thank you for viewing the detailed overview of CollPlant Biotechnologies's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CollPlant Biotechnologies (XTAE:CLGN) Business Description

Traded in Other Exchanges
Address
4 Oppenheimer Street, P.O. Box 4132, Weizmann Science Park, Rehovot, ISR, 7670104
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The company's revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing.

CollPlant Biotechnologies (XTAE:CLGN) Headlines

From GuruFocus

CollPlant To Present at the Aesthetics Innovation Summit 2022

By PRNewswire PRNewswire 04-13-2022

CollPlant Issues Letter to Shareholders

By PRNewswire PRNewswire 01-05-2022